БИЗНЕС-ЛОГИСТИЧЕСКИЙ ПОДХОД К ИССЛЕДОВАНИЮ ФАРМАЦЕВТИЧЕСКОГО РЫНКА ПРЕПАРАТОВ ХАБАРОВСКОГО КРАЯ ДЛЯ ЛЕЧЕНИЯ ГРИППА, ОРВИ

Abstract

Analyzing the infectious morbidity of the population, it should be noted that the predominant places in the general structure belong to such nosologies as influenza and SARS, which more than 35 million citizens get sick in the country every year. In this regard, the generated economic damage reaches, according to various sources, 50-100 billion rubles /year, while the total damage from the entire group of infectious diseases ranges from 80-125 billion rubles/year. Due to the fact that the peak incidence occurs in the autumn-spring period, it is at this time that the greatest demand for antiviral drugs (LP) is noted. Due to the high variability of the antigenic structure of RNA-containing viruses (more than two thousand variants of strains) and the airborne transmission pathway, which increases the distribution area, data infections are widespread among the population and are registered annually not by single outbreaks, but cause a wave of epidemics with a lethality of 250-650 thousand people/year. The greatest danger of these viruses is for people with not yet formed and (or) weakened immunity: children, pregnant women, the elderly, especially if it occurs not in mild or moderate, but in severe or toxic forms, causing a number of complications. The article presents an overview of the research of the Khabarovsk Territory pharmaceutical market of drugs for the treatment of influenza, acute respiratory viral infections for the period of 2016-2020. The aim of the research was to study the consumption range of drugs for the treatment of influenza and ARVI in the Khabarovsk Territory of the Russian Federation. Based on the data obtained, we can draw conclusions on the quality of this region’s pharmaceutical care to the population with influenza and ARVI in the period under review.